U.S. flag

An official website of the United States government

CO-22-0035

Through this SPA, Colorado eliminates its statewide managed care network that provided coverage to presumptively eligible beneficiaries prior to their CHIP eligibility determination and enrollment into a contracted managed care organization (MCO).

TX-22-0001

This SPA reduces copayments for brand name insulin from $35 to $25 for all CHIP members with family income above 151 percent of the federal poverty level (FPL) up to and including 201 percent of the FPL.

UT-20-0023

This SPA demonstrates the state’s compliance with section 5022 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act.

MT-20-0023

This SPA demonstrates the state’s compliance with section 5022 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act.

DE-22-0005

This SPA demonstrates compliance with requirements in the American Rescue Plan Act of 2021 (ARP) that 1) mandate coverage of COVID-19 testing, treatment, and vaccines and their administration without cost-sharing or amount, duration, or scope limitations; and 2) require states to cover, without cost sharing, the treatment of conditions that may seriously complicate COVID- 19 treatment, during the period when a beneficiary is diagnosed with or is presumed to have COVID-19.

TX-22-0031

This SPA demonstrates compliance with requirements in the American Rescue Plan Act of 2021 (ARP) that 1) mandate coverage of COVID-19 testing, treatment, and vaccines and their administration without cost-sharing or amount, duration, or scope limitations; and 2) require states to cover, without cost sharing, the treatment of conditions that may seriously complicate COVID- 19 treatment, during the period when a beneficiary is diagnosed with or is presumed to have COVID-19.

HI-22-0005

This amendment updates the Alternative Benefit Plan (ABP) pages to align with the addition of the mandatory benefit that covers routine patient costs associated with participation in qualifying clinical trials approved in SPA 22-0004.